X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2138) 2138
Publication (97) 97
Newsletter (48) 48
Book Review (24) 24
Magazine Article (11) 11
Book Chapter (6) 6
Newspaper Article (5) 5
Transcript (2) 2
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1704) 1704
male (951) 951
dapsone - administration & dosage (923) 923
female (865) 865
dapsone (844) 844
dapsone - therapeutic use (806) 806
adult (685) 685
middle aged (491) 491
drug therapy, combination (461) 461
leprosy - drug therapy (410) 410
index medicus (382) 382
dermatology (379) 379
animals (342) 342
dapsone - adverse effects (312) 312
adolescent (284) 284
treatment outcome (259) 259
aged (249) 249
child (249) 249
rifampin - administration & dosage (223) 223
pharmacology & pharmacy (194) 194
administration, oral (172) 172
drug administration schedule (171) 171
rifampin - therapeutic use (169) 169
tropical medicine (167) 167
drug therapy (162) 162
dosage and administration (154) 154
dapsone - pharmacology (145) 145
child, preschool (142) 142
follow-up studies (139) 139
drug combinations (137) 137
care and treatment (135) 135
infectious diseases (135) 135
leprosy (135) 135
leprostatic agents - administration & dosage (131) 131
time factors (129) 129
clofazimine - administration & dosage (125) 125
mice (125) 125
anti-infective agents - administration & dosage (123) 123
leprostatic agents - therapeutic use (119) 119
infant (117) 117
therapy (117) 117
anti-infective agents - therapeutic use (112) 112
mycobacterium leprae - drug effects (105) 105
pyrimethamine - therapeutic use (102) 102
health aspects (101) 101
antimalarials - therapeutic use (100) 100
research (100) 100
diagnosis (99) 99
medicine, general & internal (98) 98
retrospective studies (98) 98
dose-response relationship, drug (94) 94
recurrence (93) 93
rats (92) 92
clofazimine - therapeutic use (91) 91
pneumonia, pneumocystis - prevention & control (91) 91
complications and side effects (89) 89
risk factors (89) 89
diagnosis, differential (85) 85
drug resistance, microbial (85) 85
malaria (84) 84
dapsone - metabolism (82) 82
children (81) 81
dapsone - blood (81) 81
pathology (81) 81
skin - pathology (81) 81
biopsy (80) 80
drugs (78) 78
dermatitis herpetiformis - drug therapy (77) 77
clinical trials as topic (76) 76
pyrimethamine - administration & dosage (76) 76
methemoglobinemia - chemically induced (75) 75
acne (74) 74
drug resistance (73) 73
young adult (72) 72
anti-infective agents - adverse effects (71) 71
prevention (71) 71
case studies (69) 69
disease (69) 69
patient compliance (69) 69
skin (69) 69
research article (67) 67
methemoglobinemia (66) 66
dapsone - analogs & derivatives (65) 65
dapsone - pharmacokinetics (65) 65
immunology (65) 65
immunosuppressive agents - therapeutic use (64) 64
leprosy - microbiology (64) 64
medicine & public health (64) 64
dermatology & venereal diseases (61) 61
analysis (59) 59
antimalarials - administration & dosage (59) 59
aids (58) 58
anti-inflammatory agents - therapeutic use (58) 58
microbiology (58) 58
pediatrics (58) 58
aged, 80 and over (57) 57
efficacy (57) 57
malaria - prevention & control (57) 57
prospective studies (57) 57
public, environmental & occupational health (57) 57
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2037) 2037
French (69) 69
German (48) 48
Japanese (12) 12
Russian (11) 11
Spanish (9) 9
Dutch (6) 6
Korean (4) 4
Danish (3) 3
Chinese (2) 2
Portuguese (2) 2
Arabic (1) 1
Hebrew (1) 1
Hungarian (1) 1
Italian (1) 1
Lithuanian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Dermatology, ISSN 0007-0963, 11/2017, Volume 177, Issue 5, pp. 1299 - 1305
Journal Article
Journal Article
Journal Article
Journal Article
Pathophysiology : the official journal of the International Society for Pathophysiology, ISSN 0928-4680, 07/2019
Dapsone (4, 4'-diaminodiphenylsulfone, DDS) is a potent anti-inflammatory and antibacterial compound which has been used in the treatment of leprosy,... 
Journal Article
Malaria Journal, ISSN 1475-2875, 2011, Volume 10, Issue 1, pp. 263 - 263
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2010, Volume 54, Issue 5, pp. 1762 - 1768
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2009, Volume 4, Issue 8, p. e6682
Background: Chlorproguanil-dapsone-artesunate (CDA) was developed as an affordable, simple, fixed-dose artemisinin-based combination therapy for use in Africa.... 
BIOLOGY | Malaria, Falciparum - drug therapy | Proguanil - administration & dosage | Double-Blind Method | Humans | Africa | Fluorenes - therapeutic use | Artemisinins - administration & dosage | Male | Treatment Outcome | Antimalarials - therapeutic use | Dapsone - therapeutic use | Ethanolamines - administration & dosage | Proguanil - analogs & derivatives | Proguanil - therapeutic use | Artemisinins - therapeutic use | Artesunate | Adolescent | Dapsone - administration & dosage | Ethanolamines - therapeutic use | Female | Fluorenes - administration & dosage | Lumefantrine | Patient Compliance | Child | Phosphates | Plasmodium falciparum | Care and treatment | Malaria | Medical centers | Dapsone | Clinical trials | Glycosylated hemoglobin | Product development | Chlorproguanil | Drugs | Adolescence | Dehydrogenases | Artemisinin | Erythrocytes | Family medical history | Glucose | Males | Epidemiology | Tropical diseases | Glucose 6 phosphate dehydrogenase | Randomization | Glucose dehydrogenase | Hemoglobin | Population | Children | Safety | Adolescents | Glucosephosphate dehydrogenase | Drug dosages | Public health | Teaching hospitals | Vector-borne diseases | Medical research | Hematology | Anemia | Patients | Medicine | Polymerase chain reaction | Chemotherapy | Medical centres | Womens health | Artemether | Mutation | Females
Journal Article
Journal Article